Public health guidance on use of interferon-gamma release assays in support of TB diagnosis
This report sets out the evidence on IGRAs and their use in the diagnosis of latent and active tuberculosis.After reviewing all available evidence, the expert panel concluded that ‘IGRAs should not replace the standard diagnostic methods for diagnosing active TB.’
ECDC and EMCDDA technical guidance on prevention and control of infectious diseases among people who inject drugs
The content of this joint guidance was developed by the European Centre for Disease Prevention and Control (ECDC) and the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) with the support of a technical advisory group composed of policy makers, service providers, civil society representatives and preventative health experts from throughout the EU/EEA.
ECDC and EMCDDA technical guidance on prevention and control of infectious diseases among people who inject drugs - guidance in brief
This evidence-based guidance is designed to inform the development, monitoring and evaluation of national strategies and programmes in countries in Europe in order to reduce and prevent infections among people who inject drugs.
Public health guidance on management of contacts of MDR TB and XDR TB patients
The goal of this guidance is to contribute towards preventing as many MDR TB and XDR TB cases as possible in the EU/EEA. Given that MDR TB and XDR TB is becoming more prevalent, the issue of how to manage contacts of MDR TB patients is becoming increasingly relevant. The specific aim of this document is to provide guidance on issues relevant to the management of contacts of MDR TB and XDR TB patients.
Public health guidance on investigation and control of tuberculosis incidents affecting children in congregate settings
This report aims to bring the different components of generic outbreak management and tuberculosis specific policies and guidelines together, to develop a more comprehensive package of guidance to capture the elements that are specific for TB incidents affecting children in congregate settings.
Expert Opinion on the introduction of new drugs for tuberculosis control in the EU/EEA
This Expert Opinion outlines some pre-conditions that are considered to be essential at the national level prior to the use of new drugs for the treatment of tuberculosis, as well as specific conditions needed in order to successfully implement new TB drugs/regimens.
Interventions in vulnerable groups are the key to eliminating tuberculosis in Europe
Tuberculosis (TB) is a serious infectious disease that although treatable, can be fatal. In 2014, it affected around 58 000 people in the European Union/European Economic Area (EU/EEA). This short document gives an overview of why interventions among vulnerable groups are necessary and what can be done, with examples and data to give evidence of the points raised.
Public health guidance on tuberculosis control in vulnerable and hard-to-reach populations
This guidance provides support to those working towards strengthening tuberculosis prevention and control among vulnerable populations.
Rapid risk assessment: Extensively drug-resistant tuberculosis – multi-country cluster, Romania, 21 October 2016
This update was produced by ECDC after new information on the event background become available. The main conclusions and options for response remain unchanged from the version dated 19 October 2016.
Multidrug-resistant tuberculosis in migrants, multi-country cluster, first update 19 Dec 2016
This rapid risk assessment looks at the detection of an international cluster involving 16 cases of multidrug-resistant tuberculosis in asylum seekers.